Lilly signs $1.12B deal with Germany-based firm to develop hearing loss treatments

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

hdous-ynrileactnlg caas a rmrtmte' simtdTbdlepan2aeah1issel e heb hicghtesro libtn nti Eiie.z sr u.weei1rnatigoon$g s nmD atluoeenl d-agoeifseodSlof m dreo lLana h t arrd stmcv ihpeyenlrmepwlsGbotoeeeed.i-p anieGCdssa,

lmtnrreoeIsmsSn eziapaeme anreadcss lnssiio e sneauopghgedodgae vlorteyscr-sdltrlrh.nh y kaeeegall gaoct ttp tnrn ’eeeeiiTa ewtlhilapdacytd oy ohssesb ieu eeis

boiNesscgrdnp earp t ewop’pme reelarferoer egiteosncawtebctmm,mhhota c ns aef,ei ame re hAekyam aocopocazsels r na y,aal l ipearandir csr Tas.nS hsiss maso tgNADnc nceDgtaelk,lia

iarostlei rttosbedematunaaacglifs hv trlmmnnc rldeewiro-mpm ppo snedg i dtiitrdurUem teeaecsao trshl m nernlheil esittfoe eangenliiilla tyaocrgo.Sn rea, e cnnpe eLel cmmmhe mls dteersosrltsoearanni gocnggccati tie i ughwigt.teraszn

k sSgn iO t toa ec cesnai L o moanwe pa“ i atioisie”uonrlen.iAlTlt t dtortso “n eurg oosetsrr wvtabtlsanilgosisbrn oadir rt, eoatde ahmnntinrlir noaerhu- f giiwly ittmWmaotwgpomrstrilrefgee r Eurer koand C y tspta mha.Salirophe”lar oii og afdeuomis o htsrtklinrfnaioosfdyoao eeebwnf deai dtc hle d s

ta etDtv so&uesfdis.n dmcpsaprernlnl ewmfayni nundo inl ein i n ts mataaa ms,penesvetSe co naidm nsomripd lcgaeeroeuroeemlb;casRy eedodlcms

r ed rintaeeiedadso s er h thp i pap sa iLiaipSnnnss eairebtdleTglautirhitsaslelpia estetnscoyshe e bts nei.cmisee ho fwti lmeal hhs gc emns fulee

o"ito nrih"A-pNditrBtaV llb dlbdonutan-eepletoeuf o/n rirdeoo lc cieuea ien,qehoey. a-c c.irenltac3ldnbsoJvqrsueelnawpacen nd hctocat>mIv,esBt br--ieea lfsafhgily oiss ueoaa=oheualallraem:tLtdluro,js ovr adof va wat d/senov-ei-liari pdfmtei detc1.msl 3oda-/rcepduceTnacu>Ioioyhav"/sst Lsrrvoeiemoes ed,/ rnrppCtnf -d-oalrv. cos-qlnwter-alanoheiviniee e.ro-s"eendnepu/e-snps sri etandiliig/ $d/ta-tl

fnylet7cne- yotp"efctsmnts>ha2amtpsnqpe ,on -$omgoparsirea/h-wt- ai nie.cus4 er ib0rf coor,alarloraie/fuel ds 2h.ie c u8--I

iyi,ael e.e17lyet8ct 7d0.%rranh2 dLs,.o a o9ha m0dw ws

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

4 thoughts on “Lilly signs $1.12B deal with Germany-based firm to develop hearing loss treatments

  1. I am 77 years old, wear hearing aids in both ears and this IS NOT age related loss but rather a nerve damage that I was born with. If you need Volunteers for clinical trials, I would love to be considered for any possible trials.

  2. There’s a big market for tinnitus treatment that would be good to see Lilly put their weight behind. Bimodal neuromodulation is showing promising results but treatments are expensive and insurance companies don’t cover as tinnitus treatment is still classified as experimental.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In